BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+5.18%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11.8B
AUM Growth
+$11.8B
(+2.3%)
Cap. Flow
+$507M
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
80.71%
Holding
129
New
5
Increased
21
Reduced
21
Closed
13
Top Buys
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$333M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$202M |
| 3 |
Heron Therapeutics
HRTX
|
$54.2M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$48.5M |
| 5 |
ACGN
Aceragen, Inc. Common Stock
ACGN
|
$37.4M |
Top Sells
| 1 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$108M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$37M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$16.4M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$10M |
| 5 |
Sangamo Therapeutics
SGMO
|
$9.61M |
Sector Composition
| 1 | Healthcare | 93.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
26
DELISTED
Cymabay Therapeutics
CBAY
| $50.9M | 0.43% |
3,917,700
+925,925
| +31% | +$12M |
|
27
Rhythm Pharmaceuticals
RYTM
$6.75B
| $40.8M | 0.35% |
2,049,020
| – | – |
|
|
NVTA
28
DELISTED
Invitae Corporation
NVTA
| $39.4M | 0.33% |
8,399,411
+1,111,111
| +15% | +$5.21M |
|
|
BLUE
29
DELISTED
bluebird bio
BLUE
| $34.2M | 0.29% |
15,440
| – | – |
|
30
Abeona Therapeutics
ABEO
$356M
| $31.3M | 0.27% |
87,375
+8,000
| +10% | +$2.87M |
|
31
Halozyme
HALO
$8.75B
| $31M | 0.26% |
1,581,424
| – | – |
|
|
32
Sangamo Therapeutics
SGMO
$161M
| $30.5M | 0.26% |
1,607,579
-505,797
| -24% | -$9.61M |
|
33
Nektar Therapeutics
NKTR
$543M
| $29.3M | 0.25% |
18,360
+6,898
| +60% | +$11M |
|
|
BLCM
34
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $27.2M | 0.23% |
415,158
-88,073
| -18% | -$5.78M |
|
35
VYNE Therapeutics
VYNE
$8.09M
| $26.3M | 0.22% |
+9,722
| New | +$26.3M |
|
36
Xencor
XNCR
$594M
| $26.1M | 0.22% |
872,072
| – | – |
|
37
Galapagos
GLPG
$2.06B
| $25.9M | 0.22% |
259,894
| – | – |
|
38
Exelixis
EXEL
$9.95B
| $25.8M | 0.22% |
1,162,644
-343,855
| -23% | -$7.62M |
|
|
GWPH
39
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $25M | 0.21% |
221,800
| – | – |
|
40
Merus
MRUS
$5.04B
| $21.5M | 0.18% |
1,160,014
| – | – |
|
|
AIMT
41
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $21.5M | 0.18% |
673,908
| – | – |
|
|
ECYT
42
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $20.7M | 0.18% |
2,277,799
+1,190,476
| +109% | +$10.8M |
|
43
Intellia Therapeutics
NTLA
$1.26B
| $17.6M | 0.15% |
833,795
-311,658
| -27% | -$6.57M |
|
|
PGNX
44
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $17.2M | 0.15% |
2,306,184
-844,624
| -27% | -$6.3M |
|
45
Insmed
INSM
$30.3B
| $15.8M | 0.13% |
700,000
| – | – |
|
|
MYOK
46
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $14.2M | 0.12% |
290,264
-65,000
| -18% | -$3.17M |
|
|
BOLD
47
DELISTED
Audentes Therapeutics, Inc
BOLD
| $11.8M | 0.1% |
+393,222
| New | +$11.8M |
|
48
uniQure
QURE
$954M
| $11.8M | 0.1% |
500,000
+17,443
| +4% | +$410K |
|
|
AERI
49
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $11.7M | 0.1% |
215,655
-83,701
| -28% | -$4.54M |
|
|
CFRX
50
DELISTED
ContraFect Corporation
CFRX
| $11.6M | 0.1% |
8,941
| – | – |
|